Himani Chandna is an Associate Editor at CNN News18. She specialises in healthcare and pharmaceuticals, with a strong focus on consumer health, public health, and the latest advancements in medicine. Featured in Firstpost and CNN-News18, Himani is dedicated to making complex medical topics accessible and engaging for all audiences.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Himani Chandna's coverage primarily focuses on healthcare and pharmaceutical topics in India. She often reports on government announcements and frequently cites data.
To effectively reach out to Himani, consider providing insights related to Indian healthcare policies, pharmaceutical regulations, or drug quality control issues. Additionally, offering access to relevant data or statistics may enhance the appeal of your pitch as she regularly incorporates cited data into her articles.
Given her focus on national (India) matters within the healthcare sector, experts with firsthand experience in Indian pharmaceutical regulations and trade agreements would be well-suited for potential contributions to her articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Himani Chandna, Karishma Jain
New rules aim to stop the misuse of ‘special discounts’ that regulators say has allowed counterfeit medicines to enter the market.
By: Himani Chandna, Karishma Jain
The proposal sought mandatory disclosure of manufacturers’ batch test reports, but the Drugs Consultative Committee flagged concerns over verification and regulatory oversight.
By: Pathikrit Sen Gupta, Himani Chandna
Some medicines, such as strong painkillers and sedatives, contain narcotic drugs or psychotropic substances. While they are sold legally, they can leak into the illegal market
By: Karishma Jain, Himani Chandna
India’s obesity burden has grown significantly. According to NFHS-6, 30.7% of women aged 15 to 49 were overweight or obese in 2023-24, up from 24% in NFHS-5.
By: Pragati Ratti, Himani Chandna
WHO is seeking details from Russia on the circumstances of the death, laboratory tests and their results, contact tracing and the health status of those identified as contacts.
By: Apoorva Misra
From 100 patients in its first year to 2,300 so far this year, the clinic shows the scale of need, as Gujarat and Telangana follow suit
By: Himani Chandna, Karishma Jain
The NPPA's decision aims to make cancer treatment more affordable by curbing excessive trade margins, with patients expected to save around Rs 2,500 crore annually.
By: Pathikrit Sen Gupta, Himani Chandna
DGHS directs states and drug controllers to enforce the prohibition; CGHS had issued a similar order in 2016
By: Pathikrit Sen Gupta, Himani Chandna
The committee, headed by a NITI Aayog member, has two months from its first meeting to recommend stronger oversight, including possible statutory measures
By: Himani Chandna, Apoorva Misra
The former AIIMS director advised people to wear N-95 masks during bad air quality days, noting that air pollution worsens underlying conditions and kills quietly
